Featured Content

Bleeding Disorders

Improving the Clinical Diagnosis of Inherited Bleeding Disorders

Many unique challenges surround the diagnosis and treatment of inherited mild bleeding disorders.


Venetoclax, Hypomethylating Agents Are Changing the Treatment Landscape for Acute Myeloid Leukemia

Venetoclax and hypomethylating agents, which both demonstrate single agent activity in acute myeloid leukemia, appear to be more effective when used together.

Hematopoietic Stem Cell Transplantation

Can Modifying Microbial Diversity Change Outcomes Following Allogeneic HSCT?

Some studies have found a link between intestinal microbiota composition and development of acute graft-versus-host disease.

ASH 2018

Expert Perspective: The Role of Ibrutinib and Venetoclax in Chronic Lymphocytic Leukemia

By Prithviraj Bose, MD

Hematology Advisor asked Prithviraj Bose, MD, to discuss the latest research on treatment options for CLL presented at the ASH 2018 Annual Meeting.

Thrombotic Disorders

Updated Clinical Practice Guidelines for Venous Thromboembolism: Pregnant and Pediatric Patients

In this 3-part series, Hematology Advisor spoke with experts about the revisions to the ASH clinical practice guidelines for venous thromboembolism.

Drug Lookup

Search our drug information database which contains an extensive list of hematology drugs.

Browse drugs by:

Brand Generic Disease